BRCA1 and ovarian neoplasm: The levels of tumor-infiltrated CD8+ T cells in the HGSOC tumors reveal a positive correlation with the patients’ survival regardless of the extent of residual disease, therapy, or BRCA1 mutation (Ovarian Tumor Tissue Analysis Consortium et al., 2017).